Legend Biotech (FRA:9LB) Buildings And Improvements : €0.0 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Buildings And Improvements?

Legend Biotech's quarterly buildings and improvements increased from Sep. 2023 (€0.0 Mil) to Dec. 2023 (€63.4 Mil) but then declined from Dec. 2023 (€63.4 Mil) to Mar. 2024 (€0.0 Mil).

Legend Biotech's annual buildings and improvements increased from Dec. 2021 (€16.2 Mil) to Dec. 2022 (€47.2 Mil) and increased from Dec. 2022 (€47.2 Mil) to Dec. 2023 (€63.4 Mil).

Legend Biotech Buildings And Improvements Historical Data

The historical data trend for Legend Biotech's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Legend Biotech Buildings And Improvements Chart

Legend Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

Get a 7-Day Free Trial

33.52

29.33

16.23

47.16

63.42

Legend Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buildings And Improvements	Get a 7-Day Free Trial															-	-	-	63.42	-

Legend Biotech Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Legend Biotech (FRA:9LB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (FRA:9LB) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

LEGN:USA

Address

2101 Cottontail Lane, Somerset, NJ, USA, 08873

Website

https://www.legendbiotech.com

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.

Legend Biotech (FRA:9LB) Headlines

No Headlines